BioticsAI Turns Milestones into Momentum
BioticsAI CEO Robhy Bustami joined Isabelle Johannessen on Build Mode to describe how the startup moved from research into regulated clinical deployment. With FDA approval in hand and fresh fundraising to scale operations, Bustami emphasized that tangible wins — not just technical novelty — are what ultimately deliver patient impact.
During the conversation, Bustami highlighted the practical steps the company took to work with regulators, clinical partners and investors. He stressed that building in healthcare requires patience, rigorous evidence, and a product design mindset that prioritizes safety and real-world utility over hype.
Practical lessons for founders:
- Invest early in regulatory strategy and clinical validation to avoid costly delays later.
- Keep the team mission-focused and resilient to navigate long timelines and setbacks.
- Seek partners who can bridge research and clinical practice to accelerate adoption.
Overall, the episode highlights a positive model for AI in healthcare: pair strong technical work with disciplined clinical evidence and stakeholder collaboration. BioticsAI’s progress shows how startups can convert research breakthroughs into approved, fundable products that have a real chance to improve patient care.